Search images on Google Product Monograph
Active Ingredients:
- lidocaine hydrochloride, 4 MG/ML
- dextrose, 50 MG/ML
DIN: 00828602
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: CHLORHYDRATE DE LIDOCAÏNE À 0,4 % DANS DU DEXTROSE À 5 % INJECTABLE
Schedule: Ethical
Company: BAXTER CORPORATION
ATC:
- C01 - CARDIAC THERAPY (ATC, WHO, Wiki)
- C01B - ANTIARRHYTHMICS, CLASS I AND III (ATC, WHO)
- C01BB - Antiarrhythmics, class Ib (ATC, WHO)
- C01BB01 - LIDOCAINE (WHO)
Reference brand drug: Xylocard
Pharmaceutical standard: USP